Show simple item record

Charakterisierung muriner und humaner Tumoren mit besonderem Fokus auf die Immunzellinfiltration mittels innovativer bildgebender Verfahren

dc.contributor.advisorMißbach-Güntner, Jeannine Dr.
dc.contributor.authorKremer, Andreas Falk
dc.date.accessioned2024-08-23T10:07:01Z
dc.date.available2024-10-02T00:50:20Z
dc.date.issued2024-08-23
dc.identifier.urihttp://resolver.sub.uni-goettingen.de/purl?ediss-11858/15445
dc.identifier.urihttp://dx.doi.org/10.53846/goediss-10631
dc.format.extent86de
dc.language.isodeude
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.ddc610de
dc.titleCharakterisierung muriner und humaner Tumoren mit besonderem Fokus auf die Immunzellinfiltration mittels innovativer bildgebender Verfahrende
dc.typedoctoralThesisde
dc.title.translatedCharacterisation of murine and human tumours with a special focus on immune cell infiltration using innovative imaging techniquesde
dc.contributor.refereeAlves, Frauke Prof. Dr.
dc.date.examination2024-09-04de
dc.description.abstracteng3D imaging of the immune cell status in a complex tumour volume represents an important step towards understanding the anti-tumour immune response and a decisive predictor of the efficacy of immune checkpoint inhibition. The gold standard for this issue is histology. However, due to the limitation of the sample size and the random selection of a small tumour area, this only allows an imprecise statement to be made about the 3D distribution of immune cells in a larger volume. A promising alternative here is light sheet microscopy, which allows both tomographic fluorescence images to be taken with cellular resolution and a 3D reconstruction of an entire tumour sample to be created. Two challenges were observed for light sheet microscopy, firstly to achieve a sufficient increase in transparency of tumour samples through clearing and secondly to achieve complete immunolabelling using fluorophore-coupled antibodies (NIRF probes). Three different protocols were tested for application to tumour tissue as part of the work. The protocol used here for aqueous clearing with Clarity, which is established on brain tissue, led to tissue damage in colon carcinoma, the increase in transparency was not sufficient for larger sample pieces of 0.5 cm3 and the NIRF probes could only specifically stain marginal areas of the human colon carcinoma samples. In the subsequent immunohistochemistry (IHC), EGFR and CD31 could no longer be stained and Ki-67 could only be stained very weakly compared to the control. The second method used was solvent-based clearing with benzyl alcohol benzyl benzoate (BABB). This led to a reduction in the size of the tissue, but provided the best result in terms of clearing, as it led to a very effective increase in transparency in all the tissues examined. Further experiments showed that BABB had a negative effect on the intensity of the NIRF probes. This clearing method was therefore particularly suitable for autofluorescence imaging without subsequent NIRF probe staining. Following solvent-based clearing, the target structures EGFR, CD31 and Ki-67 could be immunohistochemically stained. The third method, so-called Klarus clearing, represents an effective option for clearing low-collagen tumours, as demonstrated in this work on human colon carcinoma. Klarus clearing works with thiodiethanol, a non-toxic agent. This third method was able to ensure both a sufficient increase in transparency for light sheet microscopy and the detection of specific CD8-positive cytotoxic T cells. Furthermore, additional immunohistochemical staining could be carried out subsequently. Finally, the 3D distribution of cytotoxic T cells in collagen-poor colon carcinoma tissue could be visualised under the light sheet microscope using the clearing method developed in this work and adapted to tumour tissue.de
dc.contributor.coRefereeStröbel, Philipp Prof. Dr.
dc.subject.engclearingde
dc.identifier.urnurn:nbn:de:gbv:7-ediss-15445-3
dc.affiliation.instituteMedizinische Fakultätde
dc.subject.gokfullmedizinde
dc.description.embargoed2024-10-02de
dc.identifier.ppn1899485546
dc.notes.confirmationsentConfirmation sent 2024-08-23T10:15:01de


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record